{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:01:27Z","timestamp":1791946887758,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":3648,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1111\/j.1469-0691.2006.01395.x","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T08:27:34Z","timestamp":1145348854000},"page":"31-41","source":"Crossref","is-referenced-by-count":54,"special_numbering":"S3","title":["Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia"],"prefix":"10.1016","volume":"12","author":[{"suffix":"Jr","given":"T.M.","family":"File","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01395.x_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community\u2010acquired pneumonia: a meta\u2010analysis","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community\u2010acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01395.x_bib3","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1086\/324526","article-title":"Appropriate use of antimicrobials for drug\u2010resistant pneumonia: focus on the significance of \u03b2\u2010lactam\u2010resistant Streptococcus pneumoniae","volume":"34","author":"File","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2006.01395.x_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000079816","article-title":"Comparative antimicrobial susceptibility of respiratory pathogens","volume":"50","author":"Felmingham","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.40.5.1208","article-title":"Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994\u201395: results of a 30\u2010center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/430906","article-title":"Antimicrobial resistance among Streptococcus pneumonaie in the United States: Have we begun to turn the corner on resistance to certain antimicrobial classes?","volume":"41","author":"Doern","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community\u2010acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/jac\/43.5.637","article-title":"Distribution of mefE and ermB genes in macrolide\u2010resistant strains of Streptococcus pneumoniae and their variable susceptibiity to various antibiotcs","volume":"43","author":"Nishijima","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/48.5.659","article-title":"Increasing resistance of Streptococcus pneumoinae to fluoroquinolones: results of a Hong Knog multicenter study in 2000","volume":"48","author":"Ho","year":"2001","journal-title":"J Antimciob Chemther"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/jac\/49.1.173","article-title":"Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international muliresistant clones","volume":"49","author":"McGee","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1086\/319222","article-title":"Risk factors for acquisition of levofloxacin\u2010resistant Streptococcus pneumoniae: a case\u2010control study","volume":"32","author":"Ho","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2004.11.029","article-title":"Telithromycin new product overview","volume":"115","author":"File","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib15","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1128\/AAC.45.9.2427-2431.2001","article-title":"In vitro activities of the ketolides ABT\u2010773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis","volume":"45","author":"Schmitz","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib16","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid1106.050222","article-title":"Emergence and spread of Streptococcus pneumoniae with erm and mef resistance","volume":"11","author":"Farrell","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. C","key":"10.1111\/j.1469-0691.2006.01395.x_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/28.suppl_C.31","article-title":"A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe","volume":"28","author":"Baquero","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib18","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.286.15.1857","article-title":"Macrolide resistance among invasive Streptococcus pneumoniae isolates","volume":"286","author":"Hyde","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of \u03b2\u2010lactam: risk factors for carriage of penicillin\u2010resistant Streptococcus pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1086\/374556","article-title":"Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance","volume":"36","author":"Ruhe","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/338065","article-title":"The molecular epidemiology of penicillin\u2010resistant Streptococcus pneumoniae in the United States, 1994\u20132000","volume":"34","author":"Richter","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365549850160882","article-title":"Pneumonia caused by penicillin\u2010non\u2010susceptible and penicillin\u2010susceptible pneumococci in adults: a case\u2010control study","volume":"30","author":"Einarsson","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.1996.03530270034028","article-title":"Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention","volume":"275","author":"Plouffe","year":"1996","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u201397","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib26","series-title":"Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, September 22\u201325, 2001","first-page":"O-393","article-title":"Clinical and economic consequences of bacterial resistance in community\u2010acquired pneumococcal pneumonia","author":"Battleman","year":"2001"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence","volume":"29","author":"Turret","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1473-3099(02)00316-X","article-title":"Treatment of drug\u2010resistant pneumococcal pneumonia","volume":"2","author":"Garau","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00001432-200104000-00011","article-title":"Streptococcus pneumoniae respiratory tract infections","volume":"14","author":"Klugman","year":"2001","journal-title":"Curr Opin Inf Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00001432-200204000-00011","article-title":"Update on community\u2010acquired pneumonia: impact of antibiotic resistance on clinical outcomes","volume":"15","author":"Metlay","year":"2002","journal-title":"Curr Opin Inf Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib34","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the definition of susceptibility of Streptococcus pneumoniae to \u03b2\u2010lactam antibiotics","volume":"161","author":"Musher","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrug\u2010resistant pneumococcal in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1111\/j.1469-0691.2006.01395.x_bib37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin\u2010resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/49.3.433","article-title":"The in vivo\u2013in vitro paradox in pneumococcal respiratory tract infections","volume":"49","author":"Bishai","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1086\/376642","article-title":"Emergence of levofloxacin\u2010resistant pneumococci in immunocompromised adults after therapy for community\u2010acquired pneumonia","volume":"37","author":"Anderson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM200207043470115","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia [Letter]","volume":"347","author":"Ross","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.1.31","article-title":"Antibiotic therapy of community respiratory tract infection: strategies for optimal outcomes and minimized resistance emergence","volume":"49","author":"Ball","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib44","first-page":"41","article-title":"Changing trends in antimicrobial\u2010resistant pneumococci: it's not all bad news","volume":"4","author":"Low","year":"2005","journal-title":"Clin Infect Dis Supplement"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jac\/dkh458","article-title":"Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe","volume":"54","author":"Bruinsma","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1111\/j.1469-0691.2006.01395.x_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta\u2010lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2165\/00003495-200565070-00004","article-title":"Guide to selection of fluoroquinolones in patients with lower respiratory tract infections","volume":"65","author":"Shams","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0924-8579(02)00130-9","article-title":"Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug\u2010resistant strains, with pharmacokinetically enhanced amoxicillin\/clavulanate","volume":"20","author":"File","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jinf.2004.03.009","article-title":"Activity of telithromycin against key pathogens associated with community\u2010acquired respiratory tract infections","volume":"49","author":"Low","year":"2004","journal-title":"Journal of Infection"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib50","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1378\/chest.125.5.1888","article-title":"Guidelines for empiric antimicrobial prescribing in community\u2010acquired pneumonia","volume":"125","author":"File","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib51","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community\u2010acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1111\/j.1469-0691.2006.01395.x_bib52","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community\u2010acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community\u2010acquired pneumonia: an evidence\u2010based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.idc.2004.07.011","article-title":"Antimicrobial therapy of community\u2010acquired pneumonia","volume":"18","author":"File","year":"2004","journal-title":"Inf Dis Clinics North Am"},{"issue":"Suppl. IV","key":"10.1111\/j.1469-0691.2006.01395.x_bib55","first-page":"iv1","article-title":"Guidelines for the management of community\u2010acquired pneumonia in adults","volume":"56","author":"British Thoracic Society","year":"2001","journal-title":"Thorax"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib56","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2010polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01395.x_bib57","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00006454-200110000-00008","article-title":"Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day\u2010care centre attendees","volume":"20","author":"Dagan","year":"2001","journal-title":"Pediatr Infect Dis J"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14613203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T01:48:41Z","timestamp":1555552121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14613203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":57,"alternative-id":["S1198743X14613203"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01395.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}